Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 594.25
+1.85 (0.31%)
Jan 28, 2026, 9:30 AM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 332.7 billion as of January 27, 2026.
Market Cap
332.70B
Enterprise Value
323.48B
Revenue
20.77B
Ranking
n/a
PE Ratio
64.30
Stock Price
594.25
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 332.70B, a decrease of -18.89%. That is a compound annual growth rate of -33.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 332.70B | -9.07% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 592.65B |
| OneSource Specialty Pharma | 164.13B |
| Concord Biotech | 130.55B |
| Blue Jet Healthcare | 75.02B |
| Supriya Lifescience | 57.63B |
| Zota Health Care | 40.27B |
| Dishman Carbogen Amcis | 32.82B |
| Panacea Biotec | 22.30B |